Overview

A Study of the Safety, Tolerability, and Pharmacokinetics of Orally Administered Venglustat and Itraconazole in Healthy Adult Male Participants

Status:
COMPLETED

Trial end date:
2018-10-14

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess in healthy adult male participants the effects of itraconazole on the pharmacokinetics of venglustat and to assess the safety and tolerability of venglustat with and without coadministration of itraconazole. The maximum duration for participants from screening is between 32 to 62 days.

Phase:

PHASE1

Details

Lead Sponsor:

Genzyme, a Sanofi Company

Treatments:

Itraconazole
venglustat